Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

Cristina R. Ferrone¹, David T. Ting², Mohammad Shahid^1,3, Ioannis T. Konstantinidis¹, Francesco Sabbatino¹, Lipika Goyal², Travis Rice-Stitt³, Aysha Mubeen¹, Kshitij Arora^1,3, Nabeel Bardeesey², John Miura⁴, T. Clark Gamblin⁴, Andrew X. Zhu², Darrell Borger¹, Keith D. Lillemoe¹, Miguel N. Rivera³, and Vikram Deshpande³

¹Department of Surgery, Massachusetts General Hospital, Boston, MA; ²Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA; ³Division of Pathology, Massachusetts General Hospital, Boston, MA; ⁴Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee

ERRATUM TO: ANN SURG ONCOL. DOI 10.1245/S10434-014-4247-8

Mohammad Shahid’s and Aysha Mubeen’s names are corrected as published in this erratum.

© Society of Surgical Oncology 2015 Published Online: 10 January 2015

C. R. Ferrone e-mail: CFERRONE@mgh.harvard.edu